Article info

Download PDFPDF
New aspects of an anti-tumour drug: sorafenib efficiently inhibits HCV replication
  1. Correspondence to Dr E Hildt, University of Kiel-UKSH, Institute of Infection Medicine, Molecular Medical Virology, Brunswiker Strasse. 4, D-24105 Kiel, Germany; hildt{at}infmed.uni-kiel.de
View Full Text

Citation

Himmelsbach K, Sauter D, Baumert TF, et al
New aspects of an anti-tumour drug: sorafenib efficiently inhibits HCV replication

Publication history

  • Revised July 12, 2009
  • Accepted July 21, 2009
  • First published August 25, 2009.
Online issue publication 
November 18, 2009

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.